Schott appoints new managing director for Indian pharma glass business

Pawan Kumar Shukla takes charge of Schott's tubing plant in Gujarat

Schott Glass India's new managing director, Pawan Kumar Shukla

Schott, an international specialty glass and technology group, has announced Pawan Kumar Shukla as the new managing director for Schott Glass India. Shukla brings over 25 years in the glass, lighting, pipes, and electronics industry and has a strong background in techno-commercials. Prior to this role, he was the president of Operations at Surya Roshni, an Indian multinational manufacturer for specialty glass tubing and lighting.

An alumnus of the prestigious Indian Institute of Technology, Kanpur, in ceramic engineering and material science and metallurgy, Shukla has also worked with Corning in the cathode ray tube (CRT) division as a manufacturing head for twelve years.

Commenting on his new role, he said, “India is a frontrunner of the global pharma industry and primary pharma packaging is one of the most vital components in the entire production chain. I am proud to be associated with Schott, being one of the oldest and most trusted manufacturers of tubular glass worldwide. While the domestic market is our key focus, our India plant also caters to the Asian market, thereby contributing to the pharmaceutical industry and the Indian government’s vision of becoming a global pharmaceutical hub.”

At the Jambusar facility, Shukla’s main aim would be to achieve his team’s full potential by empowering them with responsibility, trust, and acknowledgment. Further talking about the company’s overall commitment to supporting the Indian pharma industry, he added, “Schott also takes awareness of the Indian Health Ministry’s initiative to provide affordable and accessible healthcare to its citizens. Moreover, this year has brought many challenges due to the Coronavirus pandemic. But we are proud to be a contributor in a sector, where everyone has stepped up to fight the novel virus. We remain committed in our support to the country’s pharmaceutical value chains, by providing high-quality glass products for pharma packaging while ensuring the highest global safety standards.”

Patrick Markschlaeger, executive vice-president, Schott, Business Unit Tubing, said, “Schott’s Jambusar plant is one of our most advanced tubing plants worldwide. The quality of glass produced here is at par with any other production site, including Germany. We are pleased that the manufacturing site is under the capable leadership of Shukla, who is an industry stalwart himself. He brings with him decades of technical and managerial expertise in the glass manufacturing space. We look forward to seeing Schott India achieve even higher standards and success under his guidance”, he said.

Presently, Schott delivers its specialized Fiolax glass tubes to leading pharma packaging players in India and abroad to prepare primary packaging products such as vials and syringes. Supporting the world’s fight against Covid-19 with vials capable of holding up to 2 billion vaccination doses, the German leader has reached agreements and started supplying to leading pharmaceutical companies, including key players in India.

Given the exponential rise in demand for quality glass for pharma packaging, Schott had inaugurated a new tank facility in its Jambusar plant, following EUR 21 million (approximately Rs 180 crore) in 2018. Even before the Coronavirus pandemic, the company had forecasted a rapid growth trend, and had thus committed additional investments of EUR 26 million (approximately Rs 225 crore) for yet another tank facility last year. With a combined investment of EUR 47 million ( approximately Rs 405 crore) and two new plants, Schott’s India plant is well on track to double its production capacity, enabling the supply of its FIOLAX glass tubing for both domestic and export demands, it said.

Headquartered in Mainz, Germany, Schott is a leading international technology group in specialty glass, glass-ceramics, and related high-tech materials. With over 130 years of experience, the company is an innovative partner to many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive, and aviation industries. Schott has a global presence with production sites and sales offices in 34 countries, including India.

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now


Please enter your comment!
Please enter your name here